Data & Analytics

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

By

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug

Nearly every $100,000 drug approved in the last three years was for a rare disease

Nearly every $100,000 drug approved in the last three years was for a rare disease

By

This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.

Study: One-third of new drugs report safety issues

Study: One-third of new drugs report safety issues

By

Drugs approved through the accelerated approval pathway, as well as psychiatric drugs, were more likely to have a safety issue following FDA approval.

Day 2 at Health Datapalooza

Day 2 at Health Datapalooza

By

The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.

Day 1 at Health Datapalooza

Day 1 at Health Datapalooza

By

HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.

Five things for pharma marketers to know: Monday, April 24, 2017

Five things for pharma marketers to know: Monday, April 24, 2017

By

QuintilesIMS partners with Salesforce; the E.U. to decide on new EMA location by June; drugmakers boost lobbying dollars in Q1

Pharma R&D partnerships are on the rise: report

Pharma R&D partnerships are on the rise: report

By

This is likely due, in part, to the increasingly complex nature of new specialty drugs.

Off-label legal settlements do little to change prescribing patterns

Off-label legal settlements do little to change prescribing patterns

By

An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.

Large teaching hospitals more prone to breaches

Large teaching hospitals more prone to breaches

By

These facilities may be more prone to attack because there are more people at them with access to private patient data, whether to conduct medical research or educate new healthcare professionals.

Is a Crisis Brewing for Watson Health?

Is a Crisis Brewing for Watson Health?

By

In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.

Amy Molyneux, Meta

Amy Molyneux, Meta

Amy Molyneux is co-founder and EVP of Meta.

Libbe Englander, Pharm3r

Libbe Englander, Pharm3r

Libbe Englander is founder and CEO of Pharm3r.

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin is CCO of HVH Patient Precision Analytics.

Digital IDs become focus as drugmakers seek to track doctors' behavior online

Digital IDs become focus as drugmakers seek to track doctors' behavior online

By

Organizations are focusing on better ways to verify HCPs' digital identities.

Drugmakers again boost DTC spending, to $5.6 billion in 2016

Drugmakers again boost DTC spending, to $5.6 billion in 2016

By

Pfizer and Bristol-Myers Squibb were the top spenders last year.

Five things for pharma marketers to know: Friday, February 17, 2017

Five things for pharma marketers to know: Friday, February 17, 2017

By

Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March

MM&M's top 5 stories in January 2017

MM&M's top 5 stories in January 2017

By

Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation

Patients are increasingly asking docs about drugs in DTC ads: poll

Patients are increasingly asking docs about drugs in DTC ads: poll

By

Docs said patients asked about drugs from DTC ads six times in a typical week, compared to just twice a week five years ago.

6 personalization practices from Walgreens' Balance Rewards program

6 personalization practices from Walgreens' Balance Rewards program

By

How the retail pharmacy chain uses customer data to make its marketing messages relevant.

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

By

Deborah Furey will lead the agency's pilot of a new personalized marketing offering.

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

By

There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.

Five things for pharma marketers to know: Thursday, January 12, 2017

Five things for pharma marketers to know: Thursday, January 12, 2017

By

Trump says pharma is "getting away with murder"; Senate majority votes to repeal ACA; IBM Watson Health and FDA to study blockchain technology

Pharma adopts data-science culture in move toward AI

Pharma adopts data-science culture in move toward AI

By

Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.

Big data expert Hilary Mason on 3 ways to create a data-driven culture

Big data expert Hilary Mason on 3 ways to create a data-driven culture

By

The first step is to seek leadership support, she says.

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

By

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

Prescription drug spending rises 9% in 2015, to $324 billion

Prescription drug spending rises 9% in 2015, to $324 billion

By

However, the rate of drug spending slowed compared to last year, according to an analysis by the CMS.

U.S. marketers spend slightly less on digital engagement with docs than China

U.S. marketers spend slightly less on digital engagement with docs than China

By

A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.

Infographic: The physician view on EHRs

Infographic: The physician view on EHRs

Most physicians said EHRs have negatively impacted their communication with a patients.

PulsePoint launches health vertical for programmatic advertising

PulsePoint launches health vertical for programmatic advertising

By

The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.

With more marketing spend behind it, Eliquis gains on market leader Xarelto

With more marketing spend behind it, Eliquis gains on market leader Xarelto

By

BMS and Pfizer outspent Johnson & Johnson two-to-one in advertising for their oral anticoagulant last year.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.